These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Loss of glomerular polyanion in vitro induced by mononuclear blood cells from patients with minimal-change nephrotic syndrome. Bakker WW; van Luijk WH; Hené RJ; Desmit EM; van der Hem GK; Vos JT Am J Nephrol; 1986; 6(2):107-11. PubMed ID: 2422934 [TBL] [Abstract][Full Text] [Related]
24. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome. Mishra OP; Kumar R; Narayan G; Srivastava P; Abhinay A; Prasad R; Singh A; Batra VV Pediatr Nephrol; 2017 Aug; 32(8):1355-1361. PubMed ID: 28210837 [TBL] [Abstract][Full Text] [Related]
25. Interleukin 10 inhibits vascular permeability factor release by peripheral blood mononuclear cells in patients with lipoid nephrosis. Matsumoto K Nephron; 1997; 75(2):154-9. PubMed ID: 9041534 [TBL] [Abstract][Full Text] [Related]
26. Minimal change glomerulonephritis and focal glomerulosclerosis markers and 'in vitro' activity of peripheral blood mononuclear cell. Dall'Aglio P; Chizzolini C; Brigati C Proc Eur Dial Transplant Assoc; 1983; 19():673-8. PubMed ID: 6348758 [TBL] [Abstract][Full Text] [Related]
27. Infusion of peripheral blood mononuclear cell products from nephrotic children increases albuminuria in rats. Tanaka R; Yoshikawa N; Nakamura H; Ito H Nephron; 1992; 60(1):35-41. PubMed ID: 1738411 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome. Matsumoto K; Kanmatsuse K Clin Nephrol; 1999 Jul; 52(1):10-8. PubMed ID: 10442490 [TBL] [Abstract][Full Text] [Related]
30. Interleukin-4 cooperates with interleukin-10 to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome. Matsumoto K; Ohi H; Kanmatsuse K Am J Nephrol; 1999; 19(1):21-7. PubMed ID: 10085445 [TBL] [Abstract][Full Text] [Related]
31. Effect of interleukin-8 on glomerular sulfated compounds and albuminuria. Garin EH; West L; Zheng W Pediatr Nephrol; 1997 Jun; 11(3):274-9. PubMed ID: 9203172 [TBL] [Abstract][Full Text] [Related]
32. Interleukin-8 and tumor necrosis factor-alpha are increased in minimal change disease but do not alter albumin permeability. Cho MH; Lee HS; Choe BH; Kwon SH; Chung KY; Koo JH; Ko CW Am J Nephrol; 2003; 23(4):260-6. PubMed ID: 12840601 [TBL] [Abstract][Full Text] [Related]
33. [Interleukin-18 expression in peripheral blood mononuclear cells in children with steroid-resistant nephrotic syndrome]. Jiang HK; Luo G; Jiang H Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):337-40. PubMed ID: 19470251 [TBL] [Abstract][Full Text] [Related]
34. [Changes in rat glomerular polyanion and ultrastructures induced by supernatants of cultured mononuclear cells from patients with steroid-response nephrotic syndrome]. Wang Z; Liu Z Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):29-32. PubMed ID: 7657333 [TBL] [Abstract][Full Text] [Related]
35. Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes. Ishimoto T; Cara-Fuentes G; Wang H; Shimada M; Wasserfall CH; Winter WE; Rivard CJ; Araya CE; Saleem MA; Mathieson PW; Johnson RJ; Garin EH Pediatr Nephrol; 2013 Sep; 28(9):1803-12. PubMed ID: 23689904 [TBL] [Abstract][Full Text] [Related]
36. Peripheral blood lymphocyte subsets in idiopathic nephrotic syndrome of childhood. Bagga A; Vasudev AS; Moudgil A; Srivastava RN Indian J Med Res; 1996 Nov; 104():292-5. PubMed ID: 8979520 [TBL] [Abstract][Full Text] [Related]
37. [The effect of peripheral blood mononuclear cell products from children with nephrotic syndrome on thromboxane A2 metabolism]. Watanabe Y; Suzui J; Ichikawa Y; Yoshida K; Suzuki H Arerugi; 1995 May; 44(5):547-55. PubMed ID: 7619008 [TBL] [Abstract][Full Text] [Related]
38. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome. Kallen RJ; Lee SK Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808 [TBL] [Abstract][Full Text] [Related]
39. NF-kappa B p65 antagonizes IL-4 induction by c-maf in minimal change nephrotic syndrome. Valanciuté A; le Gouvello S; Solhonne B; Pawlak A; Grimbert P; Lyonnet L; Hue S; Lang P; Remy P; Salomon R; Bensman A; Guellaën G; Sahali D J Immunol; 2004 Jan; 172(1):688-98. PubMed ID: 14688382 [TBL] [Abstract][Full Text] [Related]
40. Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats. Chadban SJ; Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ Kidney Int; 1997 Jun; 51(6):1809-17. PubMed ID: 9186870 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]